[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
AI::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
metrics
Journal volumes: 30
Journal issues: 155
Articles views: 20523880
Articles downloads: 7160586

Total authors: 7794
Unique authors: 5406
Repeated authors: 2388
Repeated authors percent: 31

Submitted articles: 5106
Accepted articles: 2182
Rejected articles: 2844
Published articles: 2073

Acceptance rate: 42.73
Rejection rate: 55.7

Average Time to Accept: 194 days
Average Time to First Review: 15.3 days
Average Time to Publish: 42.7 days

Last 3 years statistics:
Submitted articles: 605
Accepted articles: 201
Rejected articles: 328
Published articles: 201

Acceptance rate: 33.22
Rejection rate: 54.21

Average Time to Accept: 107 days
Average Time to First Review: 10.6 days
Average Time to Publish: 42.2 days
____
..
:: Volume 30, Issue 4 (Bimonthly 2026) ::
Feyz Med Sci J 2026, 30(4): 391-392 Back to browse issues page
The Imperative to Rename Polycystic Ovary Syndrome as “Metabolic–Endocrine Ovarian Syndrome”
Tahere Mazoochi , Elahe Haghparast * , Elham Haghparast
Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran , elahe.haghparast77@gmail.com
Abstract:   (337 Views)
letter to Editor
Keywords: Polyendocrine Metabolic Ovarian Syndrome, Polycystic Ovary Syndrome, Terminology
     
Type of Study: Letters to the editor | Subject: medicine, paraclinic
Received: 2026/06/21 | Revised: 2026/10/4 | Accepted: 2026/08/5 | Published: 2026/08/23
References
1. Mahase E. PMOS: NICE updates assessment and review recommendations in new guidance after condition’s name change BMJ 2026; 394 :e100151 doi:10.1136/bmj-2026-100151
2. Taieb A, Asma G, Jabeur M, Fatma BA, Nassim BH, Asma BA. Rethinking the terminology: a perspective on renaming polycystic ovary syndrome for an enhanced pathophysiological understanding. Clin Med Insights Endocrinol Diabetes. 2024;17:11795514241296777. doi:10.1177/11795514241296777 PMid:39494232 PMCid:PMC11528641
3. Society for Women's Health Research (SWHR). PCOS Explored: Confronting and Closing the Gaps in Care [Internet]. Washington, DC: SWHR; 2025 Jul 3 [cited 2026 Aug 25]. Available from: https://swhr.org/pcos-explored-confronting-and-closing-the-gaps-in-care/
4. Yildiz BO. From PCOS to PMOS: beyond ovarian morphology to neuroendocrine networks. Psychoneuroendocrinology. 2026;191:107922. doi:10.1016/j.psyneuen.2026.107922 PMid:42242037
5. Teede HJ, Moran LJ, Morman R, Gibson M, Dokras A, Berry L, et al. Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey. EClinicalMedicine. 2025;84. doi:10.1016/j.eclinm.2025.103287 PMid:40687737 PMCid:PMC12273733
6. Chedraui P, Nappi RE. From 'polycystic ovary syndrome' to 'polyendocrine metabolic ovarian syndrome': why terminology matters. Gynecol Endocrinol. 2026; 42(1):2680750. doi:10.1080/09513590.2026.2680750 PMid:42228625
7. Wu P, Chew-Graham CA, Heera-Shergill N, Heald AH. Improving awareness and care in polyendocrine metabolic ovarian syndrome (formerly polycystic ovary syndrome). BMJ. 2026;393. doi:10.1136/bmj.s893 PMid:42140655
8. Bhattacharyya S, Saha S, Barik S. OHIO spectrum as a proposed modified nomenclature for polycystic ovary syndrome. Asian Pac J Reprod. 2025;14(5):191-3. doi:10.4103/apjr.apjr_231_24
9. Teede HJ, Khomami MB, Morman R, Laven JS, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329-39. doi:10.1016/S0140-6736(26)00717-8 PMid:42119588
10. Rimmer A. PCOS name change to PMOS must be managed to avoid confusing patients, says expert. BMJ. 2026;393:s955. doi: 10.1136/bmj.s955. PMID: 42140653.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mazoochi T, Haghparast E, Haghparast E. The Imperative to Rename Polycystic Ovary Syndrome as “Metabolic–Endocrine Ovarian Syndrome”. Feyz Med Sci J 2026; 30 (4) :391-392
URL: http://feyz.kaums.ac.ir/article-1-5561-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 30, Issue 4 (Bimonthly 2026) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.17 seconds with 48 queries by YEKTAWEB 4774